Society guideline links: Cervical cancer screening, prevention, and management

Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately. (See "Society guideline links: Treatment of cervical cancer".)

International

●World Health Organization (WHO): Guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention, second edition (2021)

●WHO: Introducing and scaling up testing for human papillomavirus as part of a comprehensive programme for prevention and control of cervical cancer – A step-by-step guide (2020)

●WHO: Guidelines for the use of thermal ablation for cervical pre-cancer lesions (2019)

●WHO: Comprehensive cervical cancer control – A guide to essential practice, second edition (2014)

●WHO: Guidelines for treatment of cervical intraepithelial neoplasia 2-3 and adenocarcinoma in situ – Cryotherapy, large loop excision of the transformation zone, and cold knife conization (2014)

•WHO: Guidelines on use of cryotherapy for cervical intraepithelial neoplasia (2011)

Canada

●Choosing Wisely Canada: Don't routinely screen with Pap smears if under 21 years of age or over 69 years of age (2021)

●Canadian Paediatric Society (CPS): Position statement on human papillomavirus vaccine for children and adolescents (2018)

●Public Health Agency of Canada (PHAC): Canadian immunization guide – Human papillomavirus vaccine (2017)

●BC Guidelines: Genital tract cancers in females – Human papillomavirus related cancers (cervical, vaginal, and vulvar) (2014, revised 2016)

●Canadian Task Force on Preventive Health Care (CTFPHC): Recommendations on screening for cervical cancer (2013)

●Society of Canadian Colposcopists (SCC)-Society of Obstetricians and Gynaecologists of Canada (SOGC)-Society of Gynecologic Oncology of Canada (GOC): Joint clinical practice guideline on colposcopic management of abnormal cervical cytology and histology (2012)

●Cancer Care Ontario (CCO): Cervical screening (2011)

United States

●National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), and the HIV Medicine Association (HIVMA) of the Infectious Diseases Society of America (IDSA): Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV – Human papillomavirus disease

●American College of Obstetricians and Gynecologists (ACOG): Practice advisory on updated guidelines for management of cervical cancer screening abnormalities (2020, reaffirmed 2022)

●American Society of Clinical Oncology (ASCO): Secondary prevention of cervical cancer resource-stratified guideline (2022)

●American Academy of Pediatrics (AAP): Red Book – Human papillomaviruses (2021)

●ACOG: Practice advisory on updated cervical cancer screening guidelines (2021)

●National Cancer Institute (NCI): Cervical cancer screening – Health professional version (2021)

●American Association of Oral and Maxillofacial Surgeons (AAOMS): Position paper on human papillomavirus vaccination (2020)

●American Cancer Society (ACS): Guideline on cervical cancer screening for individuals at average risk, update (2020)

●ACS: Guideline on human papillomavirus vaccination, update (2020)

●ACOG: Committee opinion on human papillomavirus vaccination (2020)

●American Society for Colposcopy and Cervical Pathology (ASCCP): Risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors, 2019 (published 2020)

●Advisory Committee on Immunization Practices (ACIP): Human papillomavirus vaccination for adults – Updated recommendations (2019)

●ACOG: Committee opinion on cervical cancer screening in low-resource settings (2015, reaffirmed 2019)

●Guidelines for cervical cancer screening in immunosuppressed women without HIV infection (2019)

●American Urological Association (AUA): Position statement on HPV vaccination for males and females (revised 2018)

●US Preventive Services Task Force (USPSTF): Final recommendation statement on cervical cancer – Screening (2018)

●ASCO: Primary prevention of cervical cancer resource-stratified guideline (2017)

●ACIP: Use of a 2-dose schedule for human papillomavirus vaccination – Updated recommendations (2016)

●ACIP: Use of 9-valent human papillomavirus (HPV) vaccine – Updated HPV vaccination recommendations (2015)

●Society of Gynecologic Oncology (SGO): Use of primary high-risk human papillomavirus testing for cervical cancer screening – Interim guidance (2015)

●ACIP: Human papillomavirus vaccination – Recommendations (2014)

●SGO: Position statement on HPV vaccination of girls and boys (2013)

●SGO: Position statement on cervical cancer screening recommendations (2012)

●SGO: Position statement on role of HPV testing HPV typing in cervical cancer prevention and detection (2011)

Europe

●European guidelines for quality assurance in cervical cancer screening, second edition (2015)

United Kingdom

●Public Health England (PHE): Guidance on cervical screening – Pathway for acceptance of new human papillomavirus tests (2019, updated 2020)

●PHE: Guidance for health professionals – HPV universal vaccination (2019)

●PHE: The Green Book – Human papillomavirus (HPV) (2013, updated 2019)

India

●Indian Council of Medical Research (ICMR): Consensus document for the management of cancer cervix (2016)

Australia–New Zealand

●Cancer Council Australia: National Cervical Screening Program – Guidelines for the management of screen-detected abnormalities, screening in specific populations, and investigation of abnormal vaginal bleeding (updated 2022)

●New Zealand Ministry of Health: Immunisation Handbook – Human papillomavirus (2020)

●Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG): National guidelines on cervical cancer screening in Australia and New Zealand (2020)

●RANZCOG: Guidelines for HPV vaccine (2019)

●Australian Technical Advisory Group on Immunisation (ATAGI): Australian Immunisation Handbook – Human papillomavirus (HPV) (2018)

●Choosing Wisely Australia: Don't routinely do a pelvic examination with a Pap smear (2016)